Subtle Medical Advances GenAI Innovation in Radiology with NVIDIA
Leveraging NVIDIA’s Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization
MENLO PARK, Calif., March 18, 2025 /PRNewswire/ — Medical imaging today faces several critical challenges. Imaging modalities like MRI, PET, and CT are used in over five hundred million patients annually for diagnosis and treatment, involving long scan times and/or potentially high radiation and contrast dosage. This not only compromises the patient experience, causing delays of care, but also burdens healthcare facilities with high operational costs. Furthermore, variability in image quality—especially in lesion visualization—can lead to diagnostic inconsistencies and hinder effective treatment planning. These issues around radiology data acquisition, which account for ~80% of imaging cost, are particularly acute when resources are constrained and where access to high-quality imaging remains limited.
Subtle Medical, the vertical leader in AI-powered imaging, has developed state-of-the-art GenAI solutions designed to overcome traditional imaging limitations.
